Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Misty Shields

Thoracic Oncology · IUSM

View

Dr. Jacob Sands

Thoracic Oncology · Dana-Farber Cancer Institute

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Rebecca Miksad

GI Oncology · BMC

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    GLDr. Gilberto Lopes
    Leading Voice

    Dr. Gilberto Lopes

    Medical Oncology · Thoracic Oncology
    University of Miami Health System
    gilberto

    Research

    Synergistic senolytic-regenerative therapy significantly extends healthspan and lifespan

    2026

    Via J Transl Med

    Research

    The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in neuroendocrine neoplasms (NENs) including small-cell lung cancer (SCLC)

    2026

    Via Cancer Treat Res Commun

    Research

    Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities

    2026

    Via Cancer

    Research

    Exercise Counseling and Referral Practices Among Oncology Care Physicians in Latin America: A Multinational Survey Study

    2026

    Via JCO Glob Oncol

    Research

    Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysis

    2026

    Via Immunotherapy

    Research

    Creatine Supplementation in Preclinical Models Receiving Immune Checkpoint Inhibitor Therapy: A Systematic Review

    2026

    Via Cureus

    Research

    Geographic, Temporal, and Sex-Specific Trends in Mesothelioma Burden in the United States, 1990-2023

    2026

    Via JCO Glob Oncol

    Research

    Tarlatamab in Previously Treated Small Cell Lung Cancer: A Real-World Experience in a Predominantly Hispanic Population with CNS Metastases

    2026

    Via Cancers (Basel)

    Research

    Multiple Chapters, One Career: Using Career Development Plans to Find Success and Satisfaction in Academic Oncology Across the Career Spectrum

    2026

    Via Am Soc Clin Oncol Educ Book

    Research

    Beyond Testing: Rethinking Access in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

    2026

    Via JCO Glob Oncol

    Research

    Liquid biopsy biomarkers for cancer detection, treatment monitoring, and clinical outcome prediction

    2026

    Via Front Cell Dev Biol

    Research

    Georgia O'Keeffe, Hannah Wilke, and Choosing One's Own Narrative-Sovereignty

    2026

    Via JAMA Oncol

    Research

    Recent Food and Drug Administration Decisions and the Future of the Development of Cancer Drugs in the US

    2026

    Via JAMA Oncol

    Research

    Cost comparison of osimertinib plus platinum-pemetrexed versus amivantamab plus lazertinib for the first-line treatment of patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer

    2026

    Via J Med Econ

    Research

    Neladalkib (NVL-655), a highly selective anaplastic lymphoma kinase (ALK) inhibitor, compared to alectinib in first-line treatment of patients with ALK-positive advanced non-small cell lung cancer: The phase 3 ALKAZAR study

    2025

    Via Journal of Clinical Oncology